More on NeoStem Q2 results

NeoStem (NBS -4%) Q2 results: Revenue: $4.5M (+2.3%); R&D Expense: $4.0M (+81.8%); SG&A Expense: $7.4M (+72.1%); Net Loss: ($12.8M) (-48.8%); Quick Assets: $33.8M (-26.7%).

No financial guidance given.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs